메뉴 건너뛰기




Volumn 47, Issue 2, 2010, Pages 100-119

Clinical applications of positron emission tomography-computed tomography in oncology

Author keywords

Fluorodeoxyglucose; Oncology; Positron emission tomography computed tomography

Indexed keywords

3' FLUOROTHYMIDINE F 18; 6 FLUORODOPA F 18; 8 CYCLOPENTYL 3 (3 18 F FLUOROPROPYL) 1 PROPYLXANTHINE; ACETIC ACID C 11; ANTINEOPLASTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CA 125 ANTIGEN; CHOLINE C 11; FLUORODEOXYGLUCOSE F 18; FLUOROETHYLTYROSINE F 18; FLUOROTYROSINE F 18; GADOTERIC ACID; IMATINIB; IODINE 123; IODINE 131; MACROGOL; METHIONINE C 11; METOMIDATE C 11; PROSTATE SPECIFIC ANTIGEN; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN RECEPTOR; SUNITINIB; THYROGLOBULIN; TYROSINE C 11; UNCLASSIFIED DRUG;

EID: 77952586885     PISSN: 0019509X     EISSN: 19984774     Source Type: Journal    
DOI: 10.4103/0019-509X.62997     Document Type: Conference Paper
Times cited : (46)

References (164)
  • 1
    • 0034796617 scopus 로고    scopus 로고
    • FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models
    • Mochizuki T, Tsukamoto E, Kuge Y, Kanegae K, Zhao S, Hikosaka K, et al. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med 2001;42:1551-5.
    • (2001) J. Nucl Med. , vol.42 , pp. 1551-1555
    • Mochizuki, T.1    Tsukamoto, E.2    Kuge, Y.3    Kanegae, K.4    Zhao, S.5    Hikosaka, K.6
  • 2
    • 0029092229 scopus 로고
    • Glucose transporter gene expression: Regulation of transcription and mRNA stability
    • McGowan KM, Long SD, Pekala PH. Glucose transporter gene expression: Regulation of transcription and mRNA stability. Pharmacol Ther 1995;66:465-505.
    • (1995) Pharmacol. Ther. , vol.66 , pp. 465-505
    • McGowan, K.M.1    Long, S.D.2    Pekala, P.H.3
  • 3
    • 0032962081 scopus 로고    scopus 로고
    • Oncological applications of FDG PET imaging: Brain tumors, colorectal cancer, lymphoma, and melanoma
    • Delbeke D. Oncological applications of FDG PET imaging: Brain tumors, colorectal cancer, lymphoma, and melanoma. J Nucl Med 1999;40:591-603.
    • (1999) J. Nucl Med. , vol.40 , pp. 591-603
    • Delbeke, D.1
  • 4
    • 0035132776 scopus 로고    scopus 로고
    • Glucose metabolism of breast cancer assessed by 18F-FDG PET: Histologic and immunohistochemical tissue analysis
    • Avril N, Menzel M, Dose J, Schelling M, Weber W, Jänicke F, et al. Glucose metabolism of breast cancer assessed by 18F-FDG PET: Histologic and immunohistochemical tissue analysis. J Nucl Med 2001;42:9-16.
    • (2001) J. Nucl Med. , vol.42 , pp. 9-16
    • Avril, N.1    Menzel, M.2    Dose, J.3    Schelling, M.4    Weber, W.5    Jänicke, F.6
  • 5
    • 0028519891 scopus 로고
    • Cancer or inflammation? A holy grail for nuclear medicine
    • Larson SM. Cancer or inflammation? A holy grail for nuclear medicine. J Nucl Med 1994;35:1653-5.
    • (1994) J. Nucl Med. , vol.35 , pp. 1653-1655
    • Larson, S.M.1
  • 6
    • 10744232930 scopus 로고    scopus 로고
    • Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: Analysis of false-positive FDG-PET findings
    • Konishi J, Yamazaki K, Tsukamoto E, Tamaki N, Onodera Y, Otake T, et al. Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: Analysis of false-positive FDG-PET findings. Respiration 2003;70:500-6.
    • (2003) Respiration , vol.70 , pp. 500-506
    • Konishi, J.1    Yamazaki, K.2    Tsukamoto, E.3    Tamaki, N.4    Onodera, Y.5    Otake, T.6
  • 7
    • 13944283362 scopus 로고    scopus 로고
    • Fluorodeoxyglucose-PET in characterizing solitary pulmonary nodules, assessing pleural diseases, and the initial staging, restaging, therapy planning, and monitoring response of lung cancer
    • Mavi A, Lakhani P, Zhuang H, Gupta NC, Alavi A. Fluorodeoxyglucose-PET in characterizing solitary pulmonary nodules, assessing pleural diseases, and the initial staging, restaging, therapy planning, and monitoring response of lung cancer. Radiol Clin North Am 2005;43:1-21.
    • (2005) Radiol. Clin. North Am. , vol.43 , pp. 1-21
    • Mavi, A.1    Lakhani, P.2    Zhuang, H.3    Gupta, N.C.4    Alavi, A.5
  • 8
    • 26944500889 scopus 로고    scopus 로고
    • Utility of 18F-FDG PET in evaluating cancers of lung
    • Acker MR, Burrell SC. Utility of 18F-FDG PET in evaluating cancers of lung. J Nucl Med Technol 2005;33:69-74.
    • (2005) J. Nucl Med. Technol. , vol.33 , pp. 69-74
    • Acker, M.R.1    Burrell, S.C.2
  • 9
    • 0035197858 scopus 로고    scopus 로고
    • Imaging of lung cancer with CT, MRI and PET
    • Haberkorn U, Schoenberg SO. Imaging of lung cancer with CT, MRI and PET. Lung Cancer2001;34: S13-23.
    • (2001) Lung Cancer , vol.34
    • Haberkorn, U.1    Schoenberg, S.O.2
  • 10
    • 0035925107 scopus 로고    scopus 로고
    • Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: A meta-analysis
    • Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: A meta-analysis. JAMA2001;285:914-24.
    • (2001) JAMA , vol.285 , pp. 914-924
    • Gould, M.K.1    Maclean, C.C.2    Kuschner, W.G.3    Rydzak, C.E.4    Owens, D.K.5
  • 11
    • 58149391080 scopus 로고    scopus 로고
    • Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography
    • Bar-Shalom R, Kagna O, Israel O, Guralnik L. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D- glucose avidity on positron emission tomography/computed tomography. Cancer 2008;113:3213-21.
    • (2008) Cancer , vol.113 , pp. 3213-3221
    • Bar-Shalom, R.1    Kagna, O.2    Israel, O.3    Guralnik, L.4
  • 12
    • 38349098945 scopus 로고    scopus 로고
    • Impact of dual-timepoint (18) F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules
    • Alkhawaldeh K, Bural G, Kumar R, Alavi A. Impact of dual-timepoint (18) F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules. Eur J Nucl Med Mol Imaging 2008;35:246-52.
    • (2008) Eur. J. Nucl Med. Mol. Imaging , vol.35 , pp. 246-252
    • Alkhawaldeh, K.1    Bural, G.2    Kumar, R.3    Alavi, A.4
  • 14
  • 15
    • 0026090580 scopus 로고
    • Imaging strategies in the staging of lung cancer
    • Webb WR, Golden JA. Imaging strategies in the staging of lung cancer. Clin Chest Med 1991;12:133-50.
    • (1991) Clin. Chest Med. , vol.12 , pp. 133-150
    • Webb, W.R.1    Golden, J.A.2
  • 16
    • 0024521093 scopus 로고
    • The value of mediastinoscopy in preoperative staging of bronchogenic carcinoma
    • Van Schil PE, Van Hee RH, Schoofs EL. The value of mediastinoscopy in preoperative staging of bronchogenic carcinoma. J Thorac Cardiovasc Surg 1989;97:240-4.
    • (1989) J. Thorac. Cardiovasc. Surg. , vol.97 , pp. 240-244
    • Van Schil, P.E.1    Van Hee, R.H.2    Schoofs, E.L.3
  • 17
    • 0023617149 scopus 로고
    • A prospective evaluation of magnetic resonance imaging, computed tomography, and mediastinoscopy in the preoperative assessment of mediastinal node status in bronchogenic carcinoma
    • Patterson GA, Ginsberg RJ, Poon PY, Cooper JD, Goldberg M, Jones D, et al. A prospective evaluation of magnetic resonance imaging, computed tomography, and mediastinoscopy in the preoperative assessment of mediastinal node status in bronchogenic carcinoma. J Thorac Cardiovasc Surg 1987;94:679-84.
    • (1987) J. Thorac. Cardiovasc. Surg. , vol.94 , pp. 679-684
    • Patterson, G.A.1    Ginsberg, R.J.2    Poon, P.Y.3    Cooper, J.D.4    Goldberg, M.5    Jones, D.6
  • 19
    • 0036930012 scopus 로고    scopus 로고
    • Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion
    • Gupta NC, Rogers JS, Graeber GM, Gregory JL, Waheed U, Mullet D, et al. Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion. Chest 2002;122:1918-24.
    • (2002) Chest , vol.122 , pp. 1918-1924
    • Gupta, N.C.1    Rogers, J.S.2    Graeber, G.M.3    Gregory, J.L.4    Waheed, U.5    Mullet, D.6
  • 20
    • 13244296615 scopus 로고    scopus 로고
    • PET/CT using 18F-FDG in suspected lung cancer recurrence: Diagnostic value and impact on patient management
    • Keidar Z, Haim N, Guralnik L, Wollner M, Bar-Shalom R, Ben-Nun A, et al. PET/CT using 18F-FDG in suspected lung cancer recurrence: Diagnostic value and impact on patient management. J Nucl Med 2004;45:1640-6.
    • (2004) J. Nucl Med. , vol.45 , pp. 1640-1646
    • Keidar, Z.1    Haim, N.2    Guralnik, L.3    Wollner, M.4    Bar-Shalom, R.5    Ben-Nun, A.6
  • 21
    • 4444346932 scopus 로고    scopus 로고
    • The accuracy of integrated PET-CT compared with dedicated PEt alone for the staging of patients with nonsmall cell lung cancer
    • Cerfolio RJ, Ojha B, Bryant AS, Raghuveer V, Mountz JM, Bartolucci AA. The accuracy of integrated PET-CT compared with dedicated PEt alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg 2004;78:1017-23.
    • (2004) Ann. Thorac. Surg. , vol.78 , pp. 1017-1023
    • Cerfolio, R.J.1    Ojha, B.2    Bryant, A.S.3    Raghuveer, V.4    Mountz, J.M.5    Bartolucci, A.A.6
  • 22
    • 0037792992 scopus 로고    scopus 로고
    • Staging of non-small cell lung cancer with integrated positronemission tomography and computed tomography
    • Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small cell lung cancer with integrated positronemission tomography and computed tomography. N Engl J Med 2003;348:2500-7.
    • (2003) N Engl. J. Med. , vol.348 , pp. 2500-2507
    • Lardinois, D.1    Weder, W.2    Hany, T.F.3    Kamel, E.M.4    Korom, S.5    Seifert, B.6
  • 23
    • 16644393039 scopus 로고    scopus 로고
    • 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer
    • Kumar R, Xiu Y, Yu JQ, Takalkar A, El-Haddad G, Potenta S, et al. 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med 2004;45:2058-62.
    • (2004) J. Nucl Med. , vol.45 , pp. 2058-2062
    • Kumar, R.1    Xiu, Y.2    Yu, J.Q.3    Takalkar, A.4    El-Haddad, G.5    Potenta, S.6
  • 24
    • 0031137948 scopus 로고    scopus 로고
    • Positron emission tomography, bronchogenic carcinoma, and the adrenals
    • Lamki LM. Positron emission tomography, bronchogenic carcinoma, and the adrenals. AJR Am J Roentgenol 1997;168:1361-2.
    • (1997) AJR Am. J. Roentgenol , vol.168 , pp. 1361-1362
    • Lamki, L.M.1
  • 25
    • 68549140265 scopus 로고    scopus 로고
    • Early prediction of response to first-line therapy using integrated 18F-FDG PET/CT for patients with advanced/metastatic non-small cell lung cancer
    • Lee DH, Kim SK, Lee HY, Lee SY, Park SH, Kim HY, et al. Early prediction of response to first-line therapy using integrated 18F-FDG PET/CT for patients with advanced/metastatic non-small cell lung cancer. J Thorac Oncol 2009;4:816-21.
    • (2009) J. Thorac. Oncol. , vol.4 , pp. 816-821
    • Lee, D.H.1    Kim, S.K.2    Lee, H.Y.3    Lee, S.Y.4    Park, S.H.5    Kim, H.Y.6
  • 26
    • 34250678597 scopus 로고    scopus 로고
    • Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CT
    • Nahmias C, Hanna WT, Wahl LM, Long MJ, Hubner KF, Townsend DW. Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CT. J Nucl Med 2007;48:744-51.
    • (2007) J. Nucl Med. , vol.48 , pp. 744-751
    • Nahmias, C.1    Hanna, W.T.2    Wahl, L.M.3    Long, M.J.4    Hubner, K.F.5    Townsend, D.W.6
  • 27
    • 6344292582 scopus 로고    scopus 로고
    • Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose- positron emission tomography scan in potentially resectable non-small cell lung cancer
    • Kelly RF, Tran T, Holmstrom A, Murar J, Segurola RJ Jr. Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer. Chest 2004;125:1413-23.
    • (2004) Chest , vol.125 , pp. 1413-1423
    • Kelly, R.F.1    Tran, T.2    Holmstrom, A.3    Murar, J.4    Segurola Jr., R.J.5
  • 30
    • 34748814336 scopus 로고    scopus 로고
    • Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy
    • Capirci C, Rampin L, Erba PA, Galeotti F, Crepaldi G, Banti E, et al. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Eur J Nucl Med Mol Imaging 2007;34:1583-93.
    • (2007) Eur. J. Nucl Med. Mol. Imaging , vol.34 , pp. 1583-1593
    • Capirci, C.1    Rampin, L.2    Erba, P.A.3    Galeotti, F.4    Crepaldi, G.5    Banti, E.6
  • 32
    • 10044237741 scopus 로고    scopus 로고
    • Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?
    • Selzner M, Hany TF, Wildbrett P, McCormack L, Kadry Z, Clavien PA. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 2004;240:1027-36.
    • (2004) Ann. Surg. , vol.240 , pp. 1027-1036
    • Selzner, M.1    Hany, T.F.2    Wildbrett, P.3    McCormack, L.4    Kadry, Z.5    Clavien, P.A.6
  • 33
    • 0031787451 scopus 로고    scopus 로고
    • Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: Review of 183, 134 screening mammograms in Albuquerque, New Mexico
    • Rosenberg RD, Hunt WC, Williamson MR, Gilliland FD, Wiest PW, Kelsey CA, et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: Review of 183, 134 screening mammograms in Albuquerque, New Mexico. Radiology 1998;209:511-8.
    • (1998) Radiology , vol.209 , pp. 511-518
    • Rosenberg, R.D.1    Hunt, W.C.2    Williamson, M.R.3    Gilliland, F.D.4    Wiest, P.W.5    Kelsey, C.A.6
  • 34
    • 0036787397 scopus 로고    scopus 로고
    • Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: An analysis of 27, 825 patient evaluations
    • Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: An analysis of 27, 825 patient evaluations. Radiology 2002;225:165-75.
    • (2002) Radiology , vol.225 , pp. 165-175
    • Kolb, T.M.1    Lichy, J.2    Newhouse, J.H.3
  • 35
    • 5444234387 scopus 로고    scopus 로고
    • Fluorodeoxyglucose-PET in the management of breast cancer
    • Kumar R, Alavi A. Fluorodeoxyglucose-PET in the management of breast cancer. Radiol Clin North Am 2004;42:1113-22.
    • (2004) Radiol. Clin. North Am. , vol.42 , pp. 1113-1122
    • Kumar, R.1    Alavi, A.2
  • 36
    • 33751017052 scopus 로고    scopus 로고
    • Stanadarized upatke value in normal breast: Effect of age, density and menopausal status
    • Kumar R, Chauhan A, Zhuang H, Chandra P, Schnall M, Alavi A. Stanadarized upatke value in normal breast: Effect of age, density and menopausal status. Mol Imaging Biol 2006;8:355-62.
    • (2006) Mol. Imaging Biol. , vol.8 , pp. 355-362
    • Kumar, R.1    Chauhan, A.2    Zhuang, H.3    Chandra, P.4    Schnall, M.5    Alavi, A.6
  • 37
    • 12344276012 scopus 로고    scopus 로고
    • A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer
    • Lovrics PJ, Chen V, Coates G, Cornacchi SD, Goldsmith CH, Law C, et al. A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer. Ann Surg Oncol 2004;11:846-53.
    • (2004) Ann. Surg. Oncol. , vol.11 , pp. 846-853
    • Lovrics, P.J.1    Chen, V.2    Coates, G.3    Cornacchi, S.D.4    Goldsmith, C.H.5    Law, C.6
  • 40
    • 0034001789 scopus 로고    scopus 로고
    • Positron emission tomography using [(18) F]fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer
    • Schelling M, Avril N, Nährig J, Kuhn W, Römer W, Sattler D, et al. Positron emission tomography using [(18) F]fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Clin Oncol 2000;18:1689-95.
    • (2000) J. Clin. Oncol. , vol.18 , pp. 1689-1695
    • Schelling, M.1    Avril, N.2    Nährig, J.3    Kuhn, W.4    Römer, W.5    Sattler, D.6
  • 41
    • 0034002488 scopus 로고    scopus 로고
    • Positron emission tomography using [(18) F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy
    • Smith IC, Welch AE, Hutcheon AW, Miller ID, Payne S, Chilcott F, et al. Positron emission tomography using [(18) F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy. J Clin Oncol 2000;18:1676-88.
    • (2000) J. Clin. Oncol. , vol.18 , pp. 1676-1688
    • Smith, I.C.1    Welch, A.E.2    Hutcheon, A.W.3    Miller, I.D.4    Payne, S.5    Chilcott, F.6
  • 42
    • 67349209897 scopus 로고    scopus 로고
    • Role of 18F-FDG PET-CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
    • Kumar A, Kumar R, Seenu V, Gupta SD, Chawla M, Malhotra A, et al. Role of 18F-FDG PET-CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. Eur Radiol 2009;19:1347-57.
    • (2009) Eur. Radiol. , vol.19 , pp. 1347-1357
    • Kumar, A.1    Kumar, R.2    Seenu, V.3    Gupta, S.D.4    Chawla, M.5    Malhotra, A.6
  • 44
    • 0034926124 scopus 로고    scopus 로고
    • Current status of breast cancer imaging, staging and therapy
    • Wahl RL. Current status of breast cancer imaging, staging and therapy. Semin Roentgenol 2001;36:250-60.
    • (2001) Semin Roentgenol , vol.36 , pp. 250-260
    • Wahl, R.L.1
  • 45
    • 76349120360 scopus 로고    scopus 로고
    • Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer
    • Dirisamer A, Halpern BS, Flöry D, Wolf F, Beheshti M, Mayerhoefer ME, et al. Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer. Eur J Radiol 2010;73:294-9.
    • (2010) Eur. J. Radiol. , vol.73 , pp. 294-299
    • Dirisamer, A.1    Halpern, B.S.2    Flöry, D.3    Wolf, F.4    Beheshti, M.5    Mayerhoefer, M.E.6
  • 47
    • 45549090622 scopus 로고    scopus 로고
    • Comparison of gallium and PET scans at diagnosis and followup of pediatric patients with Hodgkin lymphoma
    • Hines-Thomas M, Kaste SC, Hudson MM, Howard SC, Liu WA, Wu J, et al. Comparison of gallium and PET scans at diagnosis and followup of pediatric patients with Hodgkin lymphoma. Pediatr Blood Cancer 2008;51:198-203.
    • (2008) Pediatr. Blood Cancer , vol.51 , pp. 198-203
    • Hines-Thomas, M.1    Kaste, S.C.2    Hudson, M.M.3    Howard, S.C.4    Liu, W.A.5    Wu, J.6
  • 48
    • 5444248062 scopus 로고    scopus 로고
    • Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomas
    • Kumar R, Maillard I, Schuster SJ, Alavi A. Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomas. Radiol Clin North Am 2004;42:1083-100.
    • (2004) Radiol. Clin. North Am. , vol.42 , pp. 1083-1100
    • Kumar, R.1    Maillard, I.2    Schuster, S.J.3    Alavi, A.4
  • 49
    • 48349111946 scopus 로고    scopus 로고
    • Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with hodgkin and aggressive non hodgkin lymphoma
    • Pelosi E, Pregno P, Penna D, Deandreis D, Chiappella A, Limerutti G, et al. Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma. Radiol Med 2008;113:578-90.
    • (2008) Radiol. Med. , vol.113 , pp. 578-590
    • Pelosi, E.1    Pregno, P.2    Penna, D.3    Deandreis, D.4    Chiappella, A.5    Limerutti, G.6
  • 51
    • 71049176527 scopus 로고    scopus 로고
    • Bone and [(18) F]Fluorodeoxyglucose positron-emission tomography/computed tomography scanning for the assessment of osseous involvement in Hodgkin lymphoma in children and young adults
    • Shulkin BL, Goodin GS, McCarville MB, Kaste SC, Krasin MJ, Hudson MM, et al. Bone and [(18) F]Fluorodeoxyglucose positron-emission tomography/computed tomography scanning for the assessment of osseous involvement in Hodgkin lymphoma in children and young adults. Leuk Lymphoma 2009;50:1794-802.
    • (2009) Leuk Lymphoma , vol.50 , pp. 1794-1802
    • Shulkin, B.L.1    Goodin, G.S.2    McCarville, M.B.3    Kaste, S.C.4    Krasin, M.J.5    Hudson, M.M.6
  • 52
    • 16544394931 scopus 로고    scopus 로고
    • FDG-PET in evaluation of treatment response in patients with gastrointestinal tract lymphomas
    • Kumar R, Xiu Y, Potenta S, Mavi A, Zhuang H, Yu JQ, et al. FDG-PET in evaluation of treatment response in patients with gastrointestinal tract lymphomas. J Nucl Med 2004;45:1796-803.
    • (2004) J. Nucl Med. , vol.45 , pp. 1796-1803
    • Kumar, R.1    Xiu, Y.2    Potenta, S.3    Mavi, A.4    Zhuang, H.5    Yu, J.Q.6
  • 53
    • 34748853773 scopus 로고    scopus 로고
    • Therapeutic evaluation and prognostic value of interim hybrid PET/CT with (18) F-FDG after three to four cycles of chemotherapy in non-Hodgkin's lymphoma
    • Zhao J, Qiao W, Wang C, Wang T, Xing Y. Therapeutic evaluation and prognostic value of interim hybrid PET/CT with (18) F-FDG after three to four cycles of chemotherapy in non-Hodgkin's lymphoma. Hematology 2007;12:423-30.
    • (2007) Hematology , vol.12 , pp. 423-430
    • Zhao, J.1    Qiao, W.2    Wang, C.3    Wang, T.4    Xing, Y.5
  • 54
    • 39449102141 scopus 로고    scopus 로고
    • The prognostic value of 18F-FDG PET-CT in the management of Hodgkin's lymphoma: Preliminary results of a prospective study
    • Paolini R, Rampin L, Rodella E, Ramazzina E, Banti E, Al-Nahhas A, et al. The prognostic value of 18F-FDG PET-CT in the management of Hodgkin's lymphoma: Preliminary results of a prospective study. Nucl Med Rev Cent East Eur 2007;10:87-90.
    • (2007) Nucl Med. Rev. Cent East Eur. , vol.10 , pp. 87-90
    • Paolini, R.1    Rampin, L.2    Rodella, E.3    Ramazzina, E.4    Banti, E.5    Al-Nahhas, A.6
  • 55
    • 0141669363 scopus 로고    scopus 로고
    • Clinical performance of PET-CT in evaluation of cancer. Additional value for diagnostic imaging and patient management
    • Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, et al. Clinical performance of PET-CT in evaluation of cancer. Additional value for diagnostic imaging and patient management. J Nucl Med 2003;44:1200-9.
    • (2003) J. Nucl Med. , vol.44 , pp. 1200-1209
    • Bar-Shalom, R.1    Yefremov, N.2    Guralnik, L.3    Gaitini, D.4    Frenkel, A.5    Kuten, A.6
  • 56
    • 18644386584 scopus 로고    scopus 로고
    • Dual modality of 18F-fluorodeoxyglucosepositron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary
    • Freudenberg LS, Fischer M, Antoch G, Jentzen W, Gutzeit A, Rosenbaum SJ, et al. Dual modality of 18F-fluorodeoxyglucosepositron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary. Med Princ Pract 2005;14:155-60.
    • (2005) Med. Princ Pract. , vol.14 , pp. 155-160
    • Freudenberg, L.S.1    Fischer, M.2    Antoch, G.3    Jentzen, W.4    Gutzeit, A.5    Rosenbaum, S.J.6
  • 57
    • 33847363932 scopus 로고    scopus 로고
    • Use of integrated 18F-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma
    • Jeong HS, Baek CH, Son YI, Ki Chung M, Kyung Lee D, Young Choi J, et al. Use of integrated 18F-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma. Head Neck 2007;29:203-10.
    • (2007) Head Neck , vol.29 , pp. 203-210
    • Jeong, H.S.1    Baek, C.H.2    Son, Y.I.3    Chung, M.K.4    Lee, D.K.5    Choi, J.Y.6
  • 58
    • 1642275593 scopus 로고    scopus 로고
    • Head and neck cancer: Clinical usefulness and accuracy of PET/CT image fusion
    • Schöder H, Yeung HW, Gonen M, Kraus D, Larson SM. Head and neck cancer: Clinical usefulness and accuracy of PET/CT image fusion. Radiology 2004;231:65-72.
    • (2004) Radiology , vol.231 , pp. 65-72
    • Schöder, H.1    Yeung, H.W.2    Gonen, M.3    Kraus, D.4    Larson, S.M.5
  • 60
    • 36749001499 scopus 로고    scopus 로고
    • Clinical impact of and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma
    • Connell CA, Corry J, Milner AD, Hogg A, Hicks RJ, Rischin D, et al. Clinical impact of and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma. Head Neck 2007;29:986-95.
    • (2007) Head Neck , vol.29 , pp. 986-995
    • Connell, C.A.1    Corry, J.2    Milner, A.D.3    Hogg, A.4    Hicks, R.J.5    Rischin, D.6
  • 61
    • 61449256606 scopus 로고    scopus 로고
    • Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging
    • Chen W, Parsons M, Torigian DA, Zhuang H, Alavi A. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging. Nucl Med Commun 2009;30:240-4.
    • (2009) Nucl Med. Commun. , vol.30 , pp. 240-244
    • Chen, W.1    Parsons, M.2    Torigian, D.A.3    Zhuang, H.4    Alavi, A.5
  • 62
    • 68349111689 scopus 로고    scopus 로고
    • Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: A meta-analysis
    • Dong MJ, Liu ZF, Zhao K, Ruan LX, Wang GL, Yang SY, et al. Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: A meta-analysis. Nucl Med Commun 2009;30:639-50.
    • (2009) Nucl Med. Commun. , vol.30 , pp. 639-650
    • Dong, M.J.1    Liu, Z.F.2    Zhao, K.3    Ruan, L.X.4    Wang, G.L.5    Yang, S.Y.6
  • 63
    • 13444301390 scopus 로고    scopus 로고
    • The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma
    • Nahas Z, Goldenberg D, Fakhry C, Ewertz M, Zeiger M, Ladenson PW, et al. The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma. Laryngoscope 2005;115:237-43.
    • (2005) Laryngoscope , vol.115 , pp. 237-243
    • Nahas, Z.1    Goldenberg, D.2    Fakhry, C.3    Ewertz, M.4    Zeiger, M.5    Ladenson, P.W.6
  • 65
    • 0034746433 scopus 로고    scopus 로고
    • 18F-DOPA positron emission tomography for tumor detection in patients with medullary thyroid carcinoma and elevated calcitonin levels
    • Hoegerle S, Altehoefer C, Ghanem N, Brink I, Moser E, Nitzsche E. 18F-DOPA positron emission tomography for tumor detection in patients with medullary thyroid carcinoma and elevated calcitonin levels. Eur J Nucl Med 2001;28:64-71.
    • (2001) Eur. J. Nucl Med. , vol.28 , pp. 64-71
    • Hoegerle, S.1    Altehoefer, C.2    Ghanem, N.3    Brink, I.4    Moser, E.5    Nitzsche, E.6
  • 66
    • 20044363992 scopus 로고    scopus 로고
    • FDG-PET/CT-guided intensity modulated head and neck radiotherapy: A pilot investigation
    • Schwartz DL, Ford EC, Rajendran J, Yueh B, Coltrera MD, Virgin J, et al. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: A pilot investigation. Head Neck 2005;27:478-87.
    • (2005) Head Neck , vol.27 , pp. 478-487
    • Schwartz, D.L.1    Ford, E.C.2    Rajendran, J.3    Yueh, B.4    Coltrera, M.D.5    Virgin, J.6
  • 67
    • 17144373700 scopus 로고    scopus 로고
    • Clinical applications of fluorodeoxyglucose-positron emission tomography in the management of malignant melanoma
    • Kumar R, Alavi A. Clinical applications of fluorodeoxyglucose-positron emission tomography in the management of malignant melanoma. Curr Opin Oncol 2005;17:154-9.
    • (2005) Curr. Opin. Oncol. , vol.17 , pp. 154-159
    • Kumar, R.1    Alavi, A.2
  • 68
    • 42449144847 scopus 로고    scopus 로고
    • Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefit
    • Constantinidou A, Hofman M, O'Doherty M, Acland KM, Healy C, Harries M. Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefit. Melanoma Res 2008;18:56-60.
    • (2008) Melanoma Res. , vol.18 , pp. 56-60
    • Constantinidou, A.1    Hofman, M.2    O'Doherty, M.3    Acland, K.M.4    Healy, C.5    Harries, M.6
  • 69
    • 53549107743 scopus 로고    scopus 로고
    • Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma
    • Singh B, Ezziddin S, Palmedo H, Reinhardt M, Strunk H, Tüting T, et al. Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma. Melanoma Res 2008;18:346-52.
    • (2008) Melanoma Res. , vol.18 , pp. 346-352
    • Singh, B.1    Ezziddin, S.2    Palmedo, H.3    Reinhardt, M.4    Strunk, H.5    Tüting, T.6
  • 70
    • 13944263273 scopus 로고    scopus 로고
    • Fluorodeoxyglucose-PET in the management of malignant melanoma
    • Kumar R, Mavi A, Bural G, Alavi A. Fluorodeoxyglucose-PET in the management of malignant melanoma. Radiol Clin North Am 2005;43:23-33.
    • (2005) Radiol. Clin. North Am , vol.43 , pp. 23-33
    • Kumar, R.1    Mavi, A.2    Bural, G.3    Alavi, A.4
  • 71
    • 0034284334 scopus 로고    scopus 로고
    • Positron emission tomography scanning in malignant melanoma: Clinical utility in patients with stage III disease
    • Tyler DS, Onaitis M, Kherani A, Hata A, Nicholson E, Keogan M, et al. Positron emission tomography scanning in malignant melanoma: Clinical utility in patients with stage III disease. Cancer 2000;89:1019-25.
    • (2000) Cancer , vol.89 , pp. 1019-1025
    • Tyler, D.S.1    Onaitis, M.2    Kherani, A.3    Hata, A.4    Nicholson, E.5    Keogan, M.6
  • 72
    • 33846019273 scopus 로고    scopus 로고
    • 2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma
    • Iagaru A, Quon A, Johnson D, Gambhir SS, McDougall IR. 2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma. Mol Imaging Biol 2007;9:50-7.
    • (2007) Mol. Imaging Biol. , vol.9 , pp. 50-57
    • Iagaru, A.1    Quon, A.2    Johnson, D.3    Gambhir, S.S.4    McDougall, I.R.5
  • 74
    • 20444417431 scopus 로고    scopus 로고
    • The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy
    • Cerfolio RJ, Bryant AS, Ohja B, Bartolucci AA, Eloubeidi MA. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. J Thorac Cardiovasc Surg 2005;129:1232-41.
    • (2005) J. Thorac. Cardiovasc. Surg. , vol.129 , pp. 1232-1241
    • Cerfolio, R.J.1    Bryant, A.S.2    Ohja, B.3    Bartolucci, A.A.4    Eloubeidi, M.A.5
  • 75
    • 0035136078 scopus 로고    scopus 로고
    • Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography
    • Kim K, Park SJ, Kim BT, Lee KS, Shim YM. Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography. Ann Thorac Surg 2001;71:290-4.
    • (2001) Ann. Thorac. Surg. , vol.71 , pp. 290-294
    • Kim, K.1    Park, S.J.2    Kim, B.T.3    Lee, K.S.4    Shim, Y.M.5
  • 76
    • 58149186740 scopus 로고    scopus 로고
    • Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: Initial results
    • Sun L, Su XH, Guan YS, Pan WM, Luo ZM, Wei JH, et al. Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: Initial results. World J Gastroenterol 2008;14:4627-32.
    • (2008) World J. Gastroenterol. , vol.14 , pp. 4627-4632
    • Sun, L.1    Su, X.H.2    Guan, Y.S.3    Pan, W.M.4    Luo, Z.M.5    Wei, J.H.6
  • 79
    • 1242307295 scopus 로고    scopus 로고
    • The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; A systematic review and meta-analysis
    • Bastiaannet E, Groen H, Jager PL, Cobben DC, van der Graaf WT, Vaalburg W, et al. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; A systematic review and meta-analysis. Cancer Treat Rev 2004;30:83-101.
    • (2004) Cancer Treat Rev. , vol.30 , pp. 83-101
    • Bastiaannet, E.1    Groen, H.2    Jager, P.L.3    Cobben, D.C.4    Van Der Graaf, W.T.5    Vaalburg, W.6
  • 80
    • 0031900784 scopus 로고    scopus 로고
    • Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma
    • Eary JF, Conrad EU, Bruckner JD, Folpe A, Hunt KJ, Mankoff DA, et al. Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma. Clin Cancer Res 1998;4:1215-20.
    • (1998) Clin. Cancer Res. , vol.4 , pp. 1215-1220
    • Eary, J.F.1    Conrad, E.U.2    Bruckner, J.D.3    Folpe, A.4    Hunt, K.J.5    Mankoff, D.A.6
  • 82
    • 0036948617 scopus 로고    scopus 로고
    • Diagnostic utility of FDG PET in multiple myeloma
    • Jadvar H, Conti PS. Diagnostic utility of FDG PET in multiple myeloma. Skeletal Radiol 2002;31:690-4.
    • (2002) Skeletal Radiol. , vol.31 , pp. 690-694
    • Jadvar, H.1    Conti, P.S.2
  • 83
    • 5444229070 scopus 로고    scopus 로고
    • PET imaging in gynecologic malignancies
    • Kumar R, Alavi A. PET imaging in gynecologic malignancies. Radiol Clin North Am 2004;42:1155-67.
    • (2004) Radiol. Clin. North Am. , vol.42 , pp. 1155-1167
    • Kumar, R.1    Alavi, A.2
  • 84
    • 33947218828 scopus 로고    scopus 로고
    • Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: Correlation with clinical or histological findings
    • Chung HH, Kang WJ, Kim JW, Park NH, Song YS, Chung JK, et al. Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: Correlation with clinical or histological findings. Eur J Nucl Med Mol Imaging 2007;34:480-6.
    • (2007) Eur. J. Nucl. Med. Mol. Imaging , vol.34 , pp. 480-486
    • Chung, H.H.1    Kang, W.J.2    Kim, J.W.3    Park, N.H.4    Song, Y.S.5    Chung, J.K.6
  • 85
    • 36649012843 scopus 로고    scopus 로고
    • Detection of recurrent ovarian cancer at MRI: Comparison with integrated PET/CT
    • Kim CK, Park BK, Choi JY, Kim BG, Han H. Detection of recurrent ovarian cancer at MRI: Comparison with integrated PET/CT. J Comput Assist Tomogr 2007;31:868-75.
    • (2007) J. Comput Assist. Tomogr , vol.31 , pp. 868-875
    • Kim, C.K.1    Park, B.K.2    Choi, J.Y.3    Kim, B.G.4    Han, H.5
  • 86
    • 0004931308 scopus 로고    scopus 로고
    • Avoiding second-look surgery and reducing costs in managing patients with ovarian cancer by applying F-18-FDG PET
    • Smith GT, Hubner KF, McDonald T, Thie JA. Avoiding second-look surgery and reducing costs in managing patients with ovarian cancer by applying F-18-FDG PET. Clin Positron Imaging1998;1:263.
    • (1998) Clin. Positron Imaging , vol.1 , pp. 263
    • Smith, G.T.1    Hubner, K.F.2    McDonald, T.3    Thie, J.A.4
  • 87
    • 34447571766 scopus 로고    scopus 로고
    • Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: Correlation with transvaginal ultrasonography, computed tomography, and histology
    • Castellucci P, Perrone AM, Picchio M, Ghi T, Farsad M, Nanni C, et al. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: Correlation with transvaginal ultrasonography, computed tomography, and histology. Nucl Med Commun 2007;28:589-95.
    • (2007) Nucl Med. Commun. , vol.28 , pp. 589-595
    • Castellucci, P.1    Perrone, A.M.2    Picchio, M.3    Ghi, T.4    Farsad, M.5    Nanni, C.6
  • 88
    • 0027714787 scopus 로고
    • Wholebody positron emission tomography with 2-[18F]-fluoro-2-deoxy-D- glucose can detect recurrent ovarian carcinoma
    • Karlan BY, Hawkins R, Hoh C, Lee M, Tse N, Cane P, et al. Wholebody positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose can detect recurrent ovarian carcinoma. Gynecol Oncol 1993;51:175-81.
    • (1993) Gynecol. Oncol. , vol.51 , pp. 175-181
    • Karlan, B.Y.1    Hawkins, R.2    Hoh, C.3    Lee, M.4    Tse, N.5    Cane, P.6
  • 90
    • 0141974973 scopus 로고    scopus 로고
    • Clinically occult recurrent ovarian cancer: Patient selection for secondary cytoreductive surgery using combined PET/CT
    • Bristow RE, del Carmen MG, Pannu HK, Cohade C, Zahurak ML, Fishman EK, et al. Clinically occult recurrent ovarian cancer: Patient selection for secondary cytoreductive surgery using combined PET/CT. Gynecol Oncol 2003;90:519-28.
    • (2003) Gynecol. Oncol. , vol.90 , pp. 519-528
    • Bristow, R.E.1    Carmen, M.G.D.2    Pannu, H.K.3    Cohade, C.4    Zahurak, M.L.5    Fishman, E.K.6
  • 92
    • 48649084362 scopus 로고    scopus 로고
    • The prognostic value of PET and PET/CT in cervical cancer
    • Grigsby PW. The prognostic value of PET and PET/CT in cervical cancer. Cancer Imaging 2008;8:146-55.
    • (2008) Cancer Imaging , vol.8 , pp. 146-155
    • Grigsby, P.W.1
  • 93
    • 67649392287 scopus 로고    scopus 로고
    • Imaging uterine cervical cancer with FDG-PET/CT: Direct comparison with PET
    • Tatsumi M, Cohade C, Bristow RE, Wahl RL. Imaging uterine cervical cancer with FDG-PET/CT: Direct comparison with PET. Mol Imaging Biol 2009;11:229-35.
    • (2009) Mol. Imaging Biol. , vol.11 , pp. 229-235
    • Tatsumi, M.1    Cohade, C.2    Bristow, R.E.3    Wahl, R.L.4
  • 94
    • 25144524980 scopus 로고    scopus 로고
    • Role of positron emission tomography in pretreatment lymph node staging of uterine cervical cancer: A prospective surgicopathologic correlation study
    • Roh JW, Seo SS, Lee S, Kang KW, Kim SK, Sim JS, et al. Role of positron emission tomography in pretreatment lymph node staging of uterine cervical cancer: A prospective surgicopathologic correlation study. Eur J Cancer 2005;41:2086-92.
    • (2005) Eur. J. Cancer , vol.41 , pp. 2086-2092
    • Roh, J.W.1    Seo, S.S.2    Lee, S.3    Kang, K.W.4    Kim, S.K.5    Sim, J.S.6
  • 96
    • 0642284541 scopus 로고    scopus 로고
    • Delayed (18) F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients
    • Ma SY, See LC, Lai CH, Chou HH, Tsai CS, Ng KK, et al. Delayed (18) F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients. J Nucl Med 2003;44:1775-83.
    • (2003) J. Nucl Med. , vol.44 , pp. 1775-1783
    • Ma, S.Y.1    See, L.C.2    Lai, C.H.3    Chou, H.H.4    Tsai, C.S.5    Ng, K.K.6
  • 97
    • 67650896451 scopus 로고    scopus 로고
    • Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients
    • Kim SK, Choi HJ, Park SY, Lee HY, Seo SS, Yoo CW, et al. Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients. Eur J Cancer 2009;45:2103-9.
    • (2009) Eur. J. Cancer , vol.45 , pp. 2103-2109
    • Kim, S.K.1    Choi, H.J.2    Park, S.Y.3    Lee, H.Y.4    Seo, S.S.5    Yoo, C.W.6
  • 98
    • 35048897536 scopus 로고    scopus 로고
    • 18F-fluoro-2-deoxy-d-glucose-positron emission tomography (PET)/PET-computed tomography in carcinoma of the cervix
    • Kumar R, Dadparvar S. 18F-fluoro-2-deoxy-d-glucose-positron emission tomography (PET)/PET-computed tomography in carcinoma of the cervix. Cancer 2007;110:1650-3.
    • (2007) Cancer , vol.110 , pp. 1650-1653
    • Kumar, R.1    Dadparvar, S.2
  • 99
    • 63049136012 scopus 로고    scopus 로고
    • MRI and PET/CT for triaging stage IB clinically operable cervical cancer to appropriate therapy: Decision analysis to assess patient outcomes
    • Pandharipande PV, Choy G, del Carmen MG, Gazelle GS, Russell AH, Lee SI. MRI and PET/CT for triaging stage IB clinically operable cervical cancer to appropriate therapy: Decision analysis to assess patient outcomes. AJR Am J Roentgenol 2009;192:802-14.
    • (2009) AJR Am. J. Roentgenol , vol.192 , pp. 802-814
    • Pandharipande, P.V.1    Choy, G.2    Carmen, M.G.D.3    Gazelle, G.S.4    Russell, A.H.5    Lee, S.I.6
  • 100
    • 67349244271 scopus 로고    scopus 로고
    • Role of carbon-11 choline PET/CT in the management of uterine carcinoma: Initial experience
    • Sofue K, Tateishi U, Sawada M, Maeda T, Terauchi T, Kano D, et al. Role of carbon-11 choline PET/CT in the management of uterine carcinoma: Initial experience. Ann Nucl Med 2009;23:235-43.
    • (2009) Ann. Nucl Med. , vol.23 , pp. 235-243
    • Sofue, K.1    Tateishi, U.2    Sawada, M.3    Maeda, T.4    Terauchi, T.5    Kano, D.6
  • 102
    • 1542346461 scopus 로고    scopus 로고
    • Treatment planning guidelines regarding the use of CT/PET-guided IMRT for cervical carcinoma with positive paraaortic lymph nodes
    • Esthappan J, Mutic S, Malyapa RS, Grigsby PW, Zoberi I, Dehdashti F, et al. Treatment planning guidelines regarding the use of CT/PET-guided IMRT for cervical carcinoma with positive paraaortic lymph nodes. Int J Radiat Oncol Biol Phys 2004;58:1289-97.
    • (2004) Int. J. Radiat. Oncol. Biol. Phys. , vol.58 , pp. 1289-1297
    • Esthappan, J.1    Mutic, S.2    Malyapa, R.S.3    Grigsby, P.W.4    Zoberi, I.5    Dehdashti, F.6
  • 104
    • 51349115130 scopus 로고    scopus 로고
    • Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer
    • Strobel K, Heinrich S, Bhure U, Soyka J, Veit-Haibach P, Pestalozzi BC, et al. Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer. J Nucl Med 2008;49:1408-13.
    • (2008) J. Nucl Med. , vol.49 , pp. 1408-1413
    • Strobel, K.1    Heinrich, S.2    Bhure, U.3    Soyka, J.4    Veit-Haibach, P.5    Pestalozzi, B.C.6
  • 105
    • 77952658807 scopus 로고    scopus 로고
    • Usefulness of (18) F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: A meta-analysis
    • Oct. 22. In press
    • Tang S, Huang G, Liu J, Liu T, Treven L, Song S, et al. Usefulness of (18) F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: A meta-analysis. Eur J Radiol 2009 Oct. 22. [In press]
    • (2009) Eur. J. Radiol.
    • Tang, S.1    Huang, G.2    Liu, J.3    Liu, T.4    Treven, L.5    Song, S.6
  • 106
    • 0036166730 scopus 로고    scopus 로고
    • Non-invasive differentiation of pancreatic lesions: Is analysis of FDG kinetics superior to semi quantitative uptake value analysis?
    • Nitzsche EU, Hoegerle S, Mix M, Brink I, Otte A, Moser E, et al. Non-invasive differentiation of pancreatic lesions: Is analysis of FDG kinetics superior to semi quantitative uptake value analysis? Eur J Nucl Med Mol Imaging 2002;29:237-42.
    • (2002) Eur. J. Nucl Med. Mol. Imaging , vol.29 , pp. 237-242
    • Nitzsche, E.U.1    Hoegerle, S.2    Mix, M.3    Brink, I.4    Otte, A.5    Moser, E.6
  • 107
    • 11144351693 scopus 로고    scopus 로고
    • F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: A prospective study
    • Sperti C, Pasquali C, Decet G, Chierichetti F, Liessi G, Pedrazzoli S. F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: A prospective study. J Gastrointest Surg 2005;9:22-8.
    • (2005) J. Gastrointest Surg. , vol.9 , pp. 22-28
    • Sperti, C.1    Pasquali, C.2    Decet, G.3    Chierichetti, F.4    Liessi, G.5    Pedrazzoli, S.6
  • 108
    • 22744437710 scopus 로고    scopus 로고
    • Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness
    • Heinrich S, Goerres GW, Schäfer M, Sagmeister M, Bauerfeind P, Pestalozzi BC, et al. Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann Surg 2005;242:235-43.
    • (2005) Ann. Surg. , vol.242 , pp. 235-243
    • Heinrich, S.1    Goerres, G.W.2    Schäfer, M.3    Sagmeister, M.4    Bauerfeind, P.5    Pestalozzi, B.C.6
  • 110
    • 10744220310 scopus 로고    scopus 로고
    • Role of positron emission tomography with 2-deoxy-2-[18F]fluoro-D-glucose in evaluating the effects of arterial infusion chemotherapy and radiotherapy on pancreatic cancer
    • Yoshioka M, Sato T, Furuya T, Shibata S, Andoh H, Asanuma Y, et al. Role of positron emission tomography with 2-deoxy-2-[18F]fluoro-D-glucose in evaluating the effects of arterial infusion chemotherapy and radiotherapy on pancreatic cancer. J Gastroenterol 2004;39:50-5.
    • (2004) J. Gastroenterol. , vol.39 , pp. 50-55
    • Yoshioka, M.1    Sato, T.2    Furuya, T.3    Shibata, S.4    Andoh, H.5    Asanuma, Y.6
  • 112
    • 70350482162 scopus 로고    scopus 로고
    • The clinical value of 18F-FDG PET/CT for investigating unexplained serum AFP elevation following interventional therapy for hepatocellular carcinom
    • Han AR, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, et al. The clinical value of 18F-FDG PET/CT for investigating unexplained serum AFP elevation following interventional therapy for hepatocellular carcinom. Hepatogastroenterology 2009;56:1111-6.
    • (2009) Hepatogastroenterology , vol.56 , pp. 1111-1116
    • Han, A.R.1    Gwak, G.Y.2    Choi, M.S.3    Lee, J.H.4    Koh, K.C.5    Paik, S.W.6
  • 114
    • 35248882487 scopus 로고    scopus 로고
    • Positron emission tomography/computer tomography in guidance of extrahepatic hepatocellular carcinoma metastasis management
    • Sun L, Guan YS, Pan WM, Chen GB, Luo ZM, Wu H. Positron emission tomography/computer tomography in guidance of extrahepatic hepatocellular carcinoma metastasis management. World J Gastroenterol 2007;13:5413-5.
    • (2007) World J. Gastroenterol. , vol.13 , pp. 5413-5415
    • Sun, L.1    Guan, Y.S.2    Pan, W.M.3    Chen, G.B.4    Luo, Z.M.5    Wu, H.6
  • 115
    • 67349183386 scopus 로고    scopus 로고
    • Evaluation of patients with hepatocellular carcinomas using [(11) C]acetate and [(18) F]FDG PET/CT: A preliminary study
    • Hwang KH, Choi DJ, Lee SY, Lee MK, Choe W. Evaluation of patients with hepatocellular carcinomas using [(11) C]acetate and [(18) F]FDG PET/CT: A preliminary study. Appl Radiat Isot 2009;67:1195-8.
    • (2009) Appl. Radiat. Isot , vol.67 , pp. 1195-1198
    • Hwang, K.H.1    Choi, D.J.2    Lee, S.Y.3    Lee, M.K.4    Choe, W.5
  • 116
    • 57149101558 scopus 로고    scopus 로고
    • A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma
    • Park JW, Kim JH, Kim SK, Kang KW, Park KW, Choi JI, et al. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma. J Nucl Med 2008;49:1912-21.
    • (2008) J. Nucl Med. , vol.49 , pp. 1912-1921
    • Park, J.W.1    Kim, J.H.2    Kim, S.K.3    Kang, K.W.4    Park, K.W.5    Choi, J.I.6
  • 117
    • 13844294023 scopus 로고    scopus 로고
    • The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: Long-term outcome of treatment with imatinib mesylate
    • Goerres GW, Stupp R, Barghouth G, Hany TF, Pestalozzi B, Dizendorf E, et al. The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: Long-term outcome of treatment with imatinib mesylate. Eur J Nucl Med Mol Imaging 2005;32:153-62.
    • (2005) Eur. J. Nucl Med. Mol. Imaging , vol.32 , pp. 153-162
    • Goerres, G.W.1    Stupp, R.2    Barghouth, G.3    Hany, T.F.4    Pestalozzi, B.5    Dizendorf, E.6
  • 118
    • 56749156278 scopus 로고    scopus 로고
    • FDG-PET and PET/CT in the clinical management of gastrointestinal stromal tumor
    • Basu S, Mohandas KM, Peshwe H, Asopa R, Vyawahare M. FDG-PET and PET/CT in the clinical management of gastrointestinal stromal tumor. Nucl Med Commun 2008;29:1026-39.
    • (2008) Nucl Med. Commun. , vol.29 , pp. 1026-1039
    • Basu, S.1    Mohandas, K.M.2    Peshwe, H.3    Asopa, R.4    Vyawahare, M.5
  • 119
    • 28244488664 scopus 로고    scopus 로고
    • (18) F-fluorodeoxyglucose positron emission tomography: Useful technique for predicting malignant potential of gastrointestinal stromal tumors
    • Kamiyama Y, Aihara R, Nakabayashi T, Mochiki E, Asao T, Kuwano H, et al. (18) F-Fluorodeoxyglucose Positron Emission Tomography: Useful Technique for Predicting Malignant Potential of Gastrointestinal Stromal Tumors. World J Surg 2005;29:1429-35.
    • (2005) World J. Surg. , vol.29 , pp. 1429-1435
    • Kamiyama, Y.1    Aihara, R.2    Nakabayashi, T.3    Mochiki, E.4    Asao, T.5    Kuwano, H.6
  • 120
  • 121
    • 5544270813 scopus 로고    scopus 로고
    • Positron emission tomography for prostate, bladder, and renal cancer
    • Schöder H, Larson SM. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med 2004;34:274-92.
    • (2004) Semin Nucl Med. , vol.34 , pp. 274-292
    • Schöder, H.1    Larson, S.M.2
  • 123
    • 36849044614 scopus 로고    scopus 로고
    • 11C-choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy
    • Reske SN, Blumstein NM, Glatting G. 11C-choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy. Eur J Nucl Med Mol Imaging 2008;35:9-17.
    • (2008) Eur. J. Nucl Med. Mol. Imaging , vol.35 , pp. 9-17
    • Reske, S.N.1    Blumstein, N.M.2    Glatting, G.3
  • 124
    • 0029888387 scopus 로고    scopus 로고
    • Metastatic prostate cancer: Initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose
    • Shreve PD, Grossman HB, Gross MD, Wahl RL. Metastatic prostate cancer: Initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose. Radiology 1996;199:751-6.
    • (1996) Radiology , vol.199 , pp. 751-756
    • Shreve, P.D.1    Grossman, H.B.2    Gross, M.D.3    Wahl, R.L.4
  • 125
    • 67649376668 scopus 로고    scopus 로고
    • PET/CT with (11) C-choline and (18) F-FDG in patients with elevated PSA after radical treatment of a prostate cancer
    • García JR, Soler M, Blanch MA, Ramírez I, Riera E, Lozano P, et al. PET/CT with (11) C-choline and (18) F-FDG in patients with elevated PSA after radical treatment of a prostate cancer. Rev Esp Med Nucl 2009;28:95-100.
    • (2009) Rev. Esp Med. Nucl , vol.28 , pp. 95-100
    • García, J.R.1    Soler, M.2    Blanch, M.A.3    Ramírez, I.4    Riera, E.5    Lozano, P.6
  • 126
    • 70349348936 scopus 로고    scopus 로고
    • Prospective study of [18F]flluorodeoxyglucose positron emission tomography/computed tomography for staging of muscleinvasive bladder carcinoma
    • Kibel AS, Dehdashti F, Katz MD, Klim AP, Grubb RL, Humphrey PA, et al. Prospective study of [18F]flluorodeoxyglucose positron emission tomography/computed tomography for staging of muscleinvasive bladder carcinoma. J Clin Oncol 2009;27:4314-20.
    • (2009) J. Clin. Oncol. , vol.27 , pp. 4314-4320
    • Kibel, A.S.1    Dehdashti, F.2    Katz, M.D.3    Klim, A.P.4    Grubb, R.L.5    Humphrey, P.A.6
  • 128
    • 0036147061 scopus 로고    scopus 로고
    • The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer
    • Safaei A, Figlin R, Hoh CK, Silverman DH, Seltzer M, Phelps ME, et al. The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer. Clin Nephrol 2002;57:56-62.
    • (2002) Clin. Nephrol. , vol.57 , pp. 56-62
    • Safaei, A.1    Figlin, R.2    Hoh, C.K.3    Silverman, D.H.4    Seltzer, M.5    Phelps, M.E.6
  • 129
    • 0141670441 scopus 로고    scopus 로고
    • Efficiency of [18F]F18-FDG-PETin characterizing renal cancer and detecting distant metastases: A comparison with CT
    • Aide N, Cappele O, Bottet P, Bensadoun H, Regeasse A, Comoz F, et al. Efficiency of [18F]F18-FDG-PETin characterizing renal cancer and detecting distant metastases: A comparison with CT. Eur J Nucl Med Mol Imaging 2003;30:1236-45.
    • (2003) Eur. J. Nucl Med. Mol. Imaging , vol.30 , pp. 1236-1245
    • Aide, N.1    Cappele, O.2    Bottet, P.3    Bensadoun, H.4    Regeasse, A.5    Comoz, F.6
  • 130
    • 5544226307 scopus 로고    scopus 로고
    • Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma
    • Kang DE, White RL Jr, Zuger JH, Sasser HC, Teigland CM. Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma. J Urol 2004;171:1806-9.
    • (2004) J. Urol. , vol.171 , pp. 1806-1809
    • Kang, D.E.1    White Jr., R.L.2    Zuger, J.H.3    Sasser, H.C.4    Teigland, C.M.5
  • 131
    • 33644857682 scopus 로고    scopus 로고
    • 2-Deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography in characterization of solid renal masses
    • Kumar R, Chauhan A, Lakhani P, Xiu Y, Zhuang H, Alavi A. 2-Deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography in characterization of solid renal masses. Mol Imaging Biol 2005;7:431-9.
    • (2005) Mol. Imaging Biol. , vol.7 , pp. 431-439
    • Kumar, R.1    Chauhan, A.2    Lakhani, P.3    Xiu, Y.4    Zhuang, H.5    Alavi, A.6
  • 132
    • 60849092923 scopus 로고    scopus 로고
    • 18F-FDG PET/CT imaging for an early assessment of response to sunitinib in metastatic renal carcinoma: Preliminary study
    • Vercellino L, Bousquet G, Baillet G, Barré E, Mathieu O, Just PA, et al. 18F-FDG PET/CT imaging for an early assessment of response to sunitinib in metastatic renal carcinoma: Preliminary study. Cancer Biother Radiopharm 2009;24:137-44.
    • (2009) Cancer Biother Radiopharm , vol.24 , pp. 137-144
    • Vercellino, L.1    Bousquet, G.2    Baillet, G.3    Barré, E.4    Mathieu, O.5    Just, P.A.6
  • 134
    • 0036009352 scopus 로고    scopus 로고
    • Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumors
    • Tsatalpas P, Beuthien-Baumann B, Kropp J, Manseck A, Tiepolt C, Hakenberg OW, et al. Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumors. Urol Int 2002;68:157-63.
    • (2002) Urol. Int. , vol.68 , pp. 157-163
    • Tsatalpas, P.1    Beuthien-Baumann, B.2    Kropp, J.3    Manseck, A.4    Tiepolt, C.5    Hakenberg, O.W.6
  • 135
    • 0036343610 scopus 로고    scopus 로고
    • The role of (18) fluoro-2-deoxyglucose positron emission tomography in initial staging and restaging after chemotherapy for testicular germ cell tumours
    • Spermon JR, De Geus-Oei LF, Kiemeney LA, Witjes JA, Oyen WJ. The role of (18) fluoro-2-deoxyglucose positron emission tomography in initial staging and restaging after chemotherapy for testicular germ cell tumours. BJU Int 2002;89:549-56.
    • (2002) BJU Int. , vol.89 , pp. 549-556
    • Spermon, J.R.1    De Geus-Oei, L.F.2    Kiemeney, L.A.3    Witjes, J.A.4    Oyen, W.J.5
  • 137
    • 28844468964 scopus 로고    scopus 로고
    • Nuclear medicine studies of the prostate, testes, and bladder
    • Jana S, Blaufox MD. Nuclear medicine studies of the prostate, testes, and bladder. Semin Nucl Med 2006;36:51-72.
    • (2006) Semin Nucl Med. , vol.36 , pp. 51-72
    • Jana, S.1    Blaufox, M.D.2
  • 138
    • 0035449028 scopus 로고    scopus 로고
    • Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma
    • De Santis M, Bokemeyer C, Becherer A, Stoiber F, Oechsle K, Kletter K, et al. Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma. J Clin Oncol 2001;19:3740-4.
    • (2001) J. Clin. Oncol. , vol.19 , pp. 3740-3744
    • De Santis, M.1    Bokemeyer, C.2    Becherer, A.3    Stoiber, F.4    Oechsle, K.5    Kletter, K.6
  • 139
    • 20244368226 scopus 로고    scopus 로고
    • FDG PET is superior to CT in the prediction of viable tumor in post-chemotherapy seminoma residuals
    • Becherer A, De Santis M, Karanikas G, Szabó M, Bokemeyer C, Dohmen BM, et al. FDG PET is superior to CT in the prediction of viable tumor in post-chemotherapy seminoma residuals. Eur J Radiol 2005;54:284-8.
    • (2005) Eur. J. Radiol. , vol.54 , pp. 284-288
    • Becherer, A.1    De Santis, M.2    Karanikas, G.3    Szabó, M.4    Bokemeyer, C.5    Dohmen, B.M.6
  • 140
    • 16844369124 scopus 로고    scopus 로고
    • The radionuclide molecular imaging and therapy of neuroendocrine tumors
    • Li S, Beheshti M. The radionuclide molecular imaging and therapy of neuroendocrine tumors. Curr Cancer Drug Targets 2005;5:139-48.
    • (2005) Curr. Cancer Drug. Targets , vol.5 , pp. 139-148
    • Li, S.1    Beheshti, M.2
  • 142
  • 144
    • 3242662501 scopus 로고    scopus 로고
    • Anatomical and functional imaging of metastatic pheochromocytoma
    • Ilias I, Pacak K. Anatomical and functional imaging of metastatic pheochromocytoma. Ann N Y Acad Sci 2004;1018:495-504.
    • (2004) Ann. N y Acad. Sci. , vol.1018 , pp. 495-504
    • Ilias, I.1    Pacak, K.2
  • 147
    • 13844321911 scopus 로고    scopus 로고
    • Metastatic carcinoid tumors: A clinical review
    • Zuetenhorst JM, Taal BG. Metastatic carcinoid tumors: A clinical review. Oncologist 2005;10:123-31.
    • (2005) Oncologist , vol.10 , pp. 123-131
    • Zuetenhorst, J.M.1    Taal, B.G.2
  • 150
    • 65349131321 scopus 로고    scopus 로고
    • Update on nuclear medicine imaging of neuroendocrine tumors
    • Goldsmith SJ. Update on nuclear medicine imaging of neuroendocrine tumors. Future Oncol 2009;5:75-84.
    • (2009) Future Oncol. , vol.5 , pp. 75-84
    • Goldsmith, S.J.1
  • 151
    • 16644393039 scopus 로고    scopus 로고
    • 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer
    • Kumar R, Xiu Y, Yu JQ, Takalkar A, El-Haddad G, Potenta S, et al. 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med 2004;45:2058-62.
    • (2004) J. Nucl Med. , vol.45 , pp. 2058-2062
    • Kumar, R.1    Xiu, Y.2    Yu, J.Q.3    Takalkar, A.4    El-Haddad, G.5    Potenta, S.6
  • 154
    • 0035542957 scopus 로고    scopus 로고
    • 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI
    • Yun M, Kim W, Alnafisi N, Lacorte L, Jang S, Alavi A. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 2001;42:1795-9.
    • (2001) J. Nucl Med. , vol.42 , pp. 1795-1799
    • Yun, M.1    Kim, W.2    Alnafisi, N.3    Lacorte, L.4    Jang, S.5    Alavi, A.6
  • 157
    • 0031838388 scopus 로고    scopus 로고
    • In vitro and in vivo primate evaluation of carbon-11-etomidate and carbon-11-metomidate as potential tracers for PET imaging of the adrenal cortex and its tumors
    • Bergström M, Bonasera TA, Lu L, Bergström E, Backlin C, Juhlin C, et al. In vitro and in vivo primate evaluation of carbon-11-etomidate and carbon-11-metomidate as potential tracers for PET imaging of the adrenal cortex and its tumors. J Nucl Med 1998;39:982-9.
    • (1998) J. Nucl Med. , vol.39 , pp. 982-989
    • Bergström, M.1    Bonasera, T.A.2    Lu, L.3    Bergström, E.4    Backlin, C.5    Juhlin, C.6
  • 158
    • 5544229749 scopus 로고    scopus 로고
    • 2-deoxy-fluorglucosepositron emission tomography imaging of the brain: Current clinical applications with emphasis on the dementias
    • Van Heertum RL, Greenstein EA, Tikofsky RS. 2-deoxy-fluorglucosepositron emission tomography imaging of the brain: Current clinical applications with emphasis on the dementias. Semin Nucl Med 2004;34:300-12.
    • (2004) Semin Nucl Med. , vol.34 , pp. 300-312
    • Van Heertum, R.L.1    Greenstein, E.A.2    Tikofsky, R.S.3
  • 159
    • 0031016159 scopus 로고    scopus 로고
    • 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma
    • Barker FG 2nd, Chang SM, Valk PE, Pounds TR, Prados MD. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma. Cancer 1997;79:115-26.
    • (1997) Cancer , vol.79 , pp. 115-126
    • Barker II, F.G.1    Chang, S.M.2    Valk, P.E.3    Pounds, T.R.4    Prados, M.D.5
  • 160
    • 16344393239 scopus 로고    scopus 로고
    • 18F-FDG PET of gliomas at delayed intervals: Improved distinction between tumor and normal gray matter
    • Spence AM, Muzi M, Mankoff DA, O'Sullivan SF, Link JM, Lewellen TK, et al. 18F-FDG PET of gliomas at delayed intervals: Improved distinction between tumor and normal gray matter. J Nucl Med 2004;45:1653-9.
    • (2004) J. Nucl Med. , vol.45 , pp. 1653-1659
    • Spence, A.M.1    Muzi, M.2    Mankoff, D.A.3    O'Sullivan, S.F.4    Link, J.M.5    Lewellen, T.K.6
  • 163
    • 14844320869 scopus 로고    scopus 로고
    • Multimodal metabolic imaging of cerebral gliomas: Positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy
    • Floeth FW, Pauleit D, Wittsack HJ, Langen KJ, Reifenberger G, Hamacher K, et al. Multimodal metabolic imaging of cerebral gliomas: Positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy. J Neurosurg 2005;102:318-27.
    • (2005) J. Neurosurg. , vol.102 , pp. 318-327
    • Floeth, F.W.1    Pauleit, D.2    Wittsack, H.J.3    Langen, K.J.4    Reifenberger, G.5    Hamacher, K.6
  • 164
    • 15044344615 scopus 로고    scopus 로고
    • O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas
    • Pauleit D, Floeth F, Hamacher K, Riemenschneider MJ, Reifenberger G, Müller HW, et al. O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain 2005;128:678-87.
    • (2005) Brain , vol.128 , pp. 678-687
    • Pauleit, D.1    Floeth, F.2    Hamacher, K.3    Riemenschneider, M.J.4    Reifenberger, G.5    Müller, H.W.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.